Success rates for drug development in solid tumors remain the lowest of the many therapeutics areas in medicine. Recent advances in drug discovery and development have transformed available therapies ...
The sarcoma treatment landscape is changing quickly and dramatically, with a growing number of FDA-approved drugs and clinical trials offering new hope and improving outcomes for patients whose ...
Clinical and Radiographic Benefit of a Patient With Metastatic Non-Small Cell Lung Cancer Harboring an EGFR::ERBB4 Fusion Through Use of EGFR Tyrosine Kinase Inhibitors In this report, we present a ...
Uterine leiomyosarcoma is a rare form of cancer. The earlier uterine leiomyosarcoma is diagnosed, the better the outlook. Uterine leiomyosarcoma accounts for 2–5% of all uterine cancers. It starts in ...
If you would like a patient care coordinator to reach out to you, please fill out our form to schedule an information call. Form: Schedule a Call with a Patient Care Coordinator Proton therapy is an ...
An expert writes about his experience as a sarcoma medical oncologist and how the field may progress with several therapies in the pipeline. As a sarcoma medical oncologist, the No. 1 question I am ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback